SMTL ID : 5hmi.2 (2 other biounits)

HDM2 in complex with a 3,3-Disubstituted Piperidine

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.74 Å

Oligo State

monomer

Ligands

1 x 62T: {4-[2-(2-hydroxyethoxy)phenyl]piperazin-1-yl}[(2R,3S)-2-propyl-1-{[4-(trifluoromethyl)pyridin-3-yl]carbonyl}-3-{[5-(trifluoromethyl)thiophen-3-yl]oxy}piperidin-3-yl]methanone(Non-covalent)

62T.1: 13 residues within 4Å: Chain A: L.39, L.42, G.43, I.46, M.47, Y.52, Q.57, V.60, F.76, V.78, H.81, I.84, Y.85 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.39, A:L.39, A:I.46, A:V.78, A:H.81, A:I.84, A:Y.85 Water bridges: A:Q.57 pi-Stacking: A:Y.52, A:H.81

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bogen, S.L. et al., Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors. Acs Med.Chem.Lett. (2016)

Release Date

2016-04-06

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence